Educational Background

Macalester College, B.A., Biology (cum laude), 2006

University of Minnesota Medical School, M.D., 2011

Residency: Internal Medicine, University of Washington, 2011–2014

Fellowship: Pulmonary, Critical Care & Sleep Medicine, University of Washington, 2015–2018

Professional Career

Assistant Professor of Medicine, Division of Pulmonary, Critical Care & Sleep Medicine, University of Washington. Principal Investigator of an NIH-funded pulmonary vascular biology laboratory. Medical Director of the UW Chronic Thromboembolic Pulmonary Hypertension (CTEPH) Program and Associate Director of the UW Hereditary Hemorrhagic Telangiectasia (HHT) Center.

Research Field

1. In vitro modeling of pulmonary arterial hypertension using bioengineered vascular platforms

2. Hemodynamic forces and pulmonary endothelial dysfunction

3. Translational multi-omics in pulmonary arterial hypertension

4. Diagnosis and management of chronic thromboembolic pulmonary hypertension

Papers, Books, etc.

Author of 44 peer-reviewed publications spanning pulmonary vascular disease, vascular biology, and related fields. Selected highlights:

Rayner SG et al. Multiphoton-guided Creation of Complex Organ-specific Microvasculature. Adv Healthc Mater. 2021.

Rayner SG et al. Zone of Uncertainty in Pulmonary Arterial Wedge Pressure Measurement. Am J Respir Crit Care Med. 2024.

Hirsch K*, Mandrycky CJ*, Kwan I, …Rayner SG. Endothelial Responses to Shear Stress and Pressure in PAH. bioRxiv. 2025 (under review).

Educational Background

1982-1988: Osaka University Graduate School of Medicine

Professional Career

2018- : Director, Department of Pediatrics and Neonatology, Osaka General Medical Center

2003-2018: Assistant Professor, Department of Pediatrics, Osaka University Graduate School of Medicine

2002-2003: Pediatrics-in-chief, Department of Pediatrics, Ikeda Municipal Hospital

1999-2002: Research Fellow, Department of Vascular Biology, Institute of Child Health, University Collage of London

Research Field

Pediatric Pulmonary Circulation and Pulmonary Hypertension

Pediatric Cardiomyopathy and Heart Failure

Congenital Heart Disease

Papers, Books, etc.

Pharmacological Treatment Practices for Patients with Congenital Heart Disease and Pulmonary Hypertension in Japan: Insights from the Japanese Association of Congenital Heart Disease Registry (JACPHR). Am J Cardiol. 2025; 257:18-25.

Current Circumstances Regarding End-of-Life Among Adult Congenital Heart Disease Patients in Japan. Circ J. 2024; 88:640-641.

Educational Background

Mar, 2010 – Feb, 2017 / College of Medicine, Catholic Kwandong University, Gangneung, Korea M.D.

Professional Career

Mar, 2022 – Feb, 2024 / Fellowship, Cardiology, Gachon University, Gil Medical Center

Mar, 2024 – Feb, 2025 / Fellowship, Cardiology, Yonsei University, Severance Hospital

Mar, 2025 – / Clinical Assistant Professor, Cardiology, Gachon University, Gil Medical Center

Research Field

General cardiology

Papers, Books, etc. presented or published by your name

Yang T, Jang Y, Chung WJ. Int J Heart Fail. 2024 Oct;6(4):176-178.

Won Y, Yeo J, Yang T, Chung WJ, Clin Hypertens. 2025 Jan 2:31:e5

Educational Background

(1977 ~ 1981) Seoul National University / BS, Pharmaceutics

(1981 ~ 1983) KAIST / MS, Biological Science

(1986 ~ 1991) Brown University / Ph.D., Biology and Medicine

Professional Career

(2001 ~ 2020) Seoul National University, College of Pharmacy and Graduate Program in Bioinformatics, Genetic Engineering (Professor)

(2020 ~ 2023) Yonsei University, College of Pharmacy and School of Medicine (Professor)

(2023 ~ present) Yonsei University, Institute for Convergence Research and Education in Advanced Technology, Yonsei University and School of Medicine (Professor)

(2010 ~ present) Ministry of Science and ICT, Medicinal Bioconvergence Research Center (Director)

(2021 ~ present) Zymedi Inc. (CEO)

Research Field

Aminoacyl-tRNA synthetase, translation, cancer biology, therapeutic target discovery

Papers, Books, etc. presented or published by your name

1.Kim DG, Choi YS, Lee YN, Lim SM, Kong JW, Song JH, Roh YA, Harmalkar DS, Lee KS, Goo JI, Cho HY, Mushtaq AU, Lee JH, Park SH, Kim DY, Min BS, Lee KY, Jeon YH, Lee SK, Lee K, Kim S*. AIMP2-DX2 provides therapeutic interface to control KRAS-driven tumorigenesis. Nature Communications 13: 2572, 2022

2.Yoon I, Nam MS, Kim HK, Moon HS, Kim SM, Jang JY, Song JA, Jeong SJ, Kim SB, Cho SM, Kim YH, Lee JH, Yang WS, Yoo HC, Kim KB, Kim MS, Yang AR, Cho KK, Park HS, Hwang GS, Hwang KY, Han JM, Kim JH, Kim S*. Glucose-dependent control of leucine metabolism by leucyl-tRNA synthetase 1. Science 367: 205, 2020

3.Lim S, Cho HY, Kim DG, Roh YA, Sin SY, Mushtaq AU, Kim MK, Bhattarai D, Sivaraman A, Lee YJ, Lee JH, Yang WS, Kim HK, Kim MH, Lee K, Jeon YH, Kim S*. Targeting the interaction of AIMP2-DX2 with HSP70 suppresses cancer development. Nature Chemical Biology 16: 31, 2020

4.Thomas XN, Burrier R, Kim S*. Biocon’s target factory. Nature Biotechnology 36: 791, 2018

5.Kim JH, Lee C, Lee M, Wang H, Kim K, Park SJ, Yoon I, Jang J, Zhao H, Kim HK, Kwon NH, Jeong SJ, Yoo HC, Kim JH, Yang JS, Lee MY, Lee CW, Yun J, Oh SJ, Kang JS, Martinis SA, Hwang KY, Guo M, Han G, Han JM, Kim S*. Control of leucine-dependent mTORC1 pathway through chemical intervention of leucyl-tRNA synthetase and RagD interaction. Nature Communications 8: 732, 2017

Educational Background

중앙대학교 사회복지학 석사

한국외국어대학교 경영학과

Professional Career

한국 폐동맥고혈압 환우회 회장

세무법인원형 세무사

Educational Background

College of Medicine-MD, Yonsei University (3/1988 - 2/1994)

Graduate School of Medicine- MS, Yonsei University (9/1996 - 8/1998)

Graduate School of Medicine- PhD, Yonsei University (3/2002 – 8/2009)

Professional Career

3/2003 – present Professor of Cardiovascular Medicine, Gachon University College of Medicine

9/2011– 8/2012 Visiting Associate Professor, Stanford University School of Medicine, Stanford, CA, USA

3/2017 – present Director, Gachon Cardiovascular Research Institute, Gachon University

5/2017 – 11/2022 Editor-in-Chief, Clinical Hypertension

1/2022 – 6/2024 Director, Office of Planning and Coordination, Gachon University Gil Medical Center

1/2021 – present President, Korean Society of Pulmonary Hypertension

3/2024 - present Chair, Planning Committee, Korean Society of Heart Failure

7/2024 – present Vice President, Gachon University Gil Medical Center

1/2025 - present Chair, Policy Committee, Korean Society of Cardiology

Research Field

His research interests primarily focus on pulmonary hypertension, heart failure, cardiac imaging including innovative device developments and medical education. His approach has deepened the understanding of pathophysiology leading to translational deep phenotyping and therapeutic options in pulmonary hypertension and heart failure. Also, he serves as President of Korean Pulmonary Hypertension Society (2021~), Chair of Planning Committee of Korean Heart Failure Society (2024~), Chair of Policy Committee of Korean Society of Cardiology (2025~) and Editor-in-Chief of Right Heart Journal (2025~), the offical journal of EASOPH.

Papers, Books, etc. presented or published by your name

13 Books and 165 peer-reviewed articles (103 SCI(E) Journals, 54 first and corresponding authors)
http://orcid.org/0000-0002-9767-7098
Scopus author ID: 36723733700
Web of Science Researcher ID: AAJ-5613-2021

Educational Background

연세의대 1998, MD

심장초음파 인증의(KSE)

Professional Career

내과 레지던트, 서울아산병원

류마티스 전임의, 인하대병원

류마티스 진료교수, 세브란스병원

Research Field

결체조직연관 폐질환, 폐동맥고혈압

Educational Background

2002 – 2008 Korea University College of Medicine, Korea; Bachelor’s degree

2013 – 2015 Korea University Graduate School, Korea; Master’s degree Internal Medicine

2016 – 2018 Korea University Graduate School, Korea; Doctor’s degree Internal Medicine

Professional Career

2016 – 2018 Fellow, Korea University Guro Hospital, Korea

2018 – 2019 Clinical Assistant Professor, Korea University Guro Hospital, Korea

2019 – 2020 Clinical Assistant Professor, Korea University Ansan Hospital, Korea

2020 – 2022 Assistant Professor, Korea University College of Medicine, Korea

2022 – date Associate Professor, Korea University College of Medicine, Korea

Research Field

Tissue regeneration

Epidemiology

Meta-analysis

Papers, Books, etc. presented or published by your name

Finger-aware Artificial Neural Network for predicting arthritis in Patients with hand pain. Artif Intell Med. 2025

Intra-articular injection of stigmasterol-loaded nanoparticles reduce pain and inhibit the inflammation and joint destruction in osteoarthritis rat model: A pilot study. Drug Deliv Transl Res. 2024

Characterization of virus-mediated autoimmunity and the consequences for pathological process in patients with systemic lupus erythematosus. Clin Rheumatol. 2023

Educational Background

B.S., Medicine, 1999 KyungHee University Medical College, Seoul, Korea

Ph.D., 2007 KyungHee University Medical College, Seoul, Korea

Professional Career

Mar 2005 - Feb 2008 Instructor, Division of Rheumatology, Dept. of Internal Medicine, Catholic University Medical College, Seoul, Korea

Mar 2008 - Feb 2013 Chief, Division of Rheumatology, Dept. of Internal Medicine, Chosun University Medical College, Gwangju, Korea

Jan 2012- Dec 2012 Visiting scholarship, Clinical research center, University of California San Diego, California, USA

Mar 2013 - Present Chief, Division of Rheumatology, Dept. of Internal Medicine, Soonchunhyang University Seoul hospital, Republic of Korea

Research Field

Currently, prof. Hyun-Sook Kim operates the CTD-ILD Multidisciplinary Clinic at Soonchunhyang University Seoul Hospital. Her clinical and research interests mainly focus on systemic sclerosis (SSc) and CTD-ILD, focuses on understanding the underlying mechanisms of SSc and CTD-ILD, particularly identifying novel biomarkers and potential therapeutic targets.
As of April 2025, she hold the positions of Director of Clinical Guidelines at the Korean College of Rheumatology (KCR) Association, President of the Imaging Research Group, and Advisor to the Scleroderma Research Group in KCR.

Papers, Books, etc. presented or published by your name

1. Full translation of “Atlas of capillaroscopy in rheumatic disease” (by Cutolo), 2017

2. Esophageal Involvement and Determinants of Perception of Esophageal Symptoms Among South Koreans With Systemic Sclerosis. Joon Seong Lee, Hyun-Sook Kim, Jung Rock Moon, Tom Ryu, Su Jin Hong, Young Sin Cho, Junseok Park, Tae Hee Lee. J Neurogastroenterol Motil. 2020;26:477-485.

3. High prevalence of salivary gland ultrasound abnormalities in systemic sclerosis. Kyung-Ann Lee, Wonho Choi, JongSun Kim, Hyun-Sook Kim. Joint Bone Spine. 2021;88:105113. doi: 10.1016/j.jbspin.2020.105113.

4. Long-term evaluation of autologous hematopoietic stem cell transplantation in a patient with progressive systemic sclerosis. Namho Kim, Jong-Sun Kim, Won-Ho Choi, Kyoung Ha Kim, Kyung-Ann Lee, Hyun-Sook Kim. Arch Rheumatol 2021;36:308-310.

5. Reliability and validity of the Korean version of the University of California-Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract instrument in patients with systemic sclerosis. Tae Hee Lee, Joon Seong Lee, Suyeon Park, Kyung-Ann Lee, Hyun-Sook Kim. Korean J Intern Med. 2021 Nov;36(6):1504-1514. doi: 10.3904/kjim.2020.190. Epub 2021 Feb 10.

6. Radiologic approach and progressive exploration of connective tissue disease-related interstitial lung disease: meeting the curiosity of rheumatologists. Hyeji Jeon, Bo Da Nam, Chong-Hyeon Yoon, Hyun-Sook Kim. J Rheum Dis 2024;31(1):3-14.

7. Effect of abatacept versus conventional synthetic disease modifying anti-rheumatic drugs on rheumatoid arthritis-associated interstitial lung disease. Kyung-Ann Lee, Bo Young Kim, Sung Soo Kim, Yun Hong Cheon, Sang-Il Lee, Sang-Hyon Kim, Jae Hyun Jung, Geun-Tae Kim, Jin-Wuk Hur, Myeung-Su Lee, Yun Sung Kim, Seung-Jae Hong, Suyeon Park, Hyun-Sook Kim. Korean J Intern Med 2024;39:855-864.

8. A pilot study of skin barrier function in patients with systemic sclerosis and primary Sjögren’s syndrome. Kyung-Ann Lee, Sooyoung Kim, Ho-Yeon Song, Moon Kyun Cho, Hyun-Sook Kim. J Rheum Dis 2024;31(4):244-252.

Educational Background

(2004.3-2008.2) Bechelor, Chung-Ang university (Major: Life science)

(2009.3-2013.2) M.D. College of Medicine, Gachon university

(2021.3-2024.8) on PhD course, College of Medicine, Gachon university

Professional Career

(2014.3-2020.2) Resident/Clinical fellow, Department of Internal Medicine, Gachon University Gil Medical Center

(2020.3-2021.2) Clinical fellow, Division of Rheumatology, Department of Internal Medicine, Seoul National University Hospital

(2021.3-2024.2) Clinical assistant professor, Division of Rheumatology, Department of Internal Medicine, Gachon University Gil Medical Center

(2024.3- ) Assistant professor, Division of Rheumatology, Department of Internal Medicine, Gachon University Gil Medical Center

Research Field

Systemic sclerosis

Inflammatory myositis

Ankylosing spondylitis

CTD PH

Papers, Books, etc. presented or published by your name

Yeo J, et al. Flare prediction after tapering the dose of tumour necrosis factor inhibitors in patients with axial spondyloarthritis: A nationwide cohort study. Rheumatology (Oxford) 2025;64(3):1155-1161.

Won Y, et al. Transition from parenteral treprostinil to selexipag aiming at hemodynamic targets in pulmonary arterial hypertension. Clin Hypertens. 2025;31(1):e5.

Yeo J, et al. Quantitative interstitial lung disease scores in idiopathic inflammatory myopathies: longitudinal changes and clinical implications. Rheumatology (Oxford). 2023;62(11):3690-3699

Yeo J, et al. Utility of the breath-holding test in patients with systemic sclerosis. Rheumatology (Oxford). 2022;61(10):4113-4118.

Yeo J, et al. Angiographic characteristics of vasculopathy in patients with idiopathic inflammatory myopathies and systemic sclerosis. Sci Rep. 2022;12(1):9051.

Yeo J, et al. Pulmonary arterial hypertension due to antiphospholipid syndrome initially mimicking chronic thromboembolic pulmonary hypertension. Clin Hypertens 2022; 28(1): 10.

Educational Background

2004 – 2010: B.S. in Medicine, Yeungnam University, Daegu, Republic of Korea

2013 – 2015: M.S. in Medicine, University of Ulsan College of Medicine, Seoul, Republic of Korea

2018 – 2021: M.D. in Medicine, University of Ulsan College of Medicine, Seoul, Republic of Korea

Professional Career

2020-2024: Assistant professor, Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine

2024-2025: Visiting scholar, Advanced Lung Disease and Transplant Program, Inova Fairfax Hospital, VA, USA

2025- : Associate professor, Department of Pulmonary and Critical Care Medicine, Asan Medical Center, University of Ulsan College of Medicine

Research Field

Interstitial lung disease

Pulmonary hypertension associated with interstitial lung disease

Lung transplantation

Papers, Books, etc. presented or published by your name

Discrepancy between pulmonary arterial wedge pressure and left ventricular end diastolic pressure in patients with interstitial lung disease, JHLT Open. 2024 Sep 29:6:100160e, 1st author

Serial Pulmonary Hemodynamics in Patients with IPF Listed for Lung Transplant, Am J Respir Crit Care Med. 2025 Feb 10. doi: 10.1164/rccm.202411-2157OC, 2nd author

Performance of the FORD Versus Other Available Models for the Noninvasive Prediction of Pulmonary Hypertension in Patients with Interstitial Lung Disease, Lung. 2025 Jan 22;203(1):27, 1st author

Educational Background

Yonsei University College of Medicine, MD, PhD

Professional Career

Associate Professor, Chief, Division of Pediatric Cardiology, Yonsei University College of Medicine

Fellow of the European Society of Cardiology (FESC)

Fellow of the American College of Cardiology (FACC)

Academic Committee Member of Korean Pulmonary Hypertension Society

Research Field

Congenital heart disease

Adult congenital heart disease

Pharmacovigiance study using WHO VigiBase database

Translational research
1. Computer fluid dynamics
2. Pulmonary arterial hypertension including nitric oxide inhalation delivery

Papers, Books, etc. presented or published by your name

1. Y. Oh, K. Park, S. Jung, M. Y.-H. Kim, S. Y. Jung*, J. Hong et al. Inhalable Nitric Oxide Delivery Systems for Pulmonary Arterial Hypertension Treatment. Small 2023, 2308936.

2. W. Choi, M. Choi, T. Jun, S. Lee, S. Y. Jung*, J. Hong et al. Templated Assembly of Silk Fibroin for a Bio-Feedstock-Derived Heart Valve Leaflet. Adv. Funct. Mater. 2023, 2307106.

3. SW Jung, SE Heo, YG Oh, YH Kim, SY Jung*, JK Hong et al. Zwitterionic Inhaler with Synergistic Therapeutics for Reprogramming of M2 Macrophage to Pro-Inflammatory Phenotype. Adv. Healthcare Mater.2023, onlie first

4. Choi M, Choi W, Hwang PTJ, Oh Y, Jun T, Ryu DY, Kim NK, Jang EH, Shin YR, Youn YN, Lee SH, Jung SY, Hong J. Engineered silk fibroin bio-hybrid artificial graft with releasing biological gas for enhanced circulatory stability and surgical performance. Int J Biol Macromol. 2025 May;309(Pt 2):142760.

5. Jung SY, Jung D, Kim AY, Seol JH, Park JM, Jung JW, et al. Selexipag as Add-on Therapy for Patients with Pulmonary Arterial Hypertension Associated with Congenital Heart Disease: A Single-Center Retrospective Study. Congeni Heart Dis. 2021;16(3):233–244.